Canada Oncology Sourcing Health Canada Regulations and Cold Chain Access in 2026
Author: Dr. Elena Vance
On July 4, 2026, Health Canada published updated guidance regarding the import of advanced oncology therapies under personal-use importation guidelines. Given the rapid evolution of targeted therapies, importing specialty drugs like Keytruda or Herceptin has become an essential practice for oncology clinics treating complex cases.
At Onco Medicine, we ensure complete compliance with Health Canada and international regulations. Providing full batch traceability, Certificate of Analysis (COA) records, and strict temperature logs helps Canadian clinical teams offer advanced oncology care with complete safety.
Regulatory & Logistics Requirements in Canada
- Health Canada Imports: Canadian regulations allow personal importation of approved medicines (up to a 90-day supply) under specific conditions, requiring a valid prescription from a licensed Canadian physician.
- Traceable Quality Control: Every batch is accompanied by documentation that validates source authenticity and chemical stability.
- Validated Cold-Chain: Shipping biologics to Canadian cities like Toronto, Vancouver, or Montreal requires robust insulation to maintain the 2–8°C window across long transit durations.
Ensuring patient safety requires structural rigour. By maintaining a secure cold chain and handling all customs declarations, Onco Medicine remains a key ally for Canadian oncologists seeking direct access to authentic specialty formulations.



